91ÖĆƬł§

Published on Market Research Reports® Inc. ()

Home > Global Hybrid Brain–Computer Interface (hBCI) Market Growth 2025-2031

Global Hybrid Brain–Computer Interface (hBCI) Market Growth 2025-2031

Publication ID: 
LPI07260141
Publication Date: 
July 9, 2025
Pages: 
123
Publisher: 
LPI
Countries: 
Global [1]
USD 3,660.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

Semiconductors [2]
Manufacturing (Computing & Electronics) [3]
Computing & Electronics [4]
Description: 

The global Hybrid Brain–Computer Interface (hBCI) market size is predicted to grow from US$ 474 million in 2025 to US$ 649 million in 2031; it is expected to grow at a CAGR of 5.4% from 2025 to 2031.
A typical hybrid BCI is also composed of one BCI and another system (which might be another BCI), and must also achieve specific goals better than a conventional system. For example, a hybrid BCI might infer user intent more accurately during imagery-based and/or visual attention-based experimental paradigms, improve the overall performance of the system, or reduce the rate of false positives during resting periods of i.e. steady-state visual evoked potential (SSVEP)-based BCI applications.
United States market for Hybrid Brain–Computer Interface (hBCI) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Hybrid Brain–Computer Interface (hBCI) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Hybrid Brain–Computer Interface (hBCI) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Hybrid Brain–Computer Interface (hBCI) players cover Neuralink, NeuroSky, NeuroPace, EMOTIV, Blackrock Neurotech, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The “Hybrid Brain–Computer Interface (hBCI) Industry Forecast” looks at past sales and reviews total world Hybrid Brain–Computer Interface (hBCI) sales in 2024, providing a comprehensive analysis by region and market sector of projected Hybrid Brain–Computer Interface (hBCI) sales for 2025 through 2031. With Hybrid Brain–Computer Interface (hBCI) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hybrid Brain–Computer Interface (hBCI) industry.
This Insight Report provides a comprehensive analysis of the global Hybrid Brain–Computer Interface (hBCI) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hybrid Brain–Computer Interface (hBCI) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hybrid Brain–Computer Interface (hBCI) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hybrid Brain–Computer Interface (hBCI) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hybrid Brain–Computer Interface (hBCI).
This report presents a comprehensive overview, market shares, and growth opportunities of Hybrid Brain–Computer Interface (hBCI) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Invasive
Non-invasive
Segmentation by Application:
Healthcare
Entertainment and Education
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Neuralink
NeuroSky
NeuroPace
EMOTIV
Blackrock Neurotech
Compumedics
Advanced Brain Monitoring
G.TEC
Neuroelectrics
Brain Products
ANT Neuro
BrainCo
Neuracle
Flexolink
NeuralFlex
Key Questions Addressed in this Report
What is the 10-year outlook for the global Hybrid Brain–Computer Interface (hBCI) market?
What factors are driving Hybrid Brain–Computer Interface (hBCI) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hybrid Brain–Computer Interface (hBCI) market opportunities vary by end market size?
How does Hybrid Brain–Computer Interface (hBCI) break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hybrid Brain–Computer Interface (hBCI) Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Hybrid Brain–Computer Interface (hBCI) by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Hybrid Brain–Computer Interface (hBCI) by Country/Region, 2020, 2024 & 2031
2.2 Hybrid Brain–Computer Interface (hBCI) Segment by Type
2.2.1 Invasive
2.2.2 Non-invasive
2.3 Hybrid Brain–Computer Interface (hBCI) Sales by Type
2.3.1 Global Hybrid Brain–Computer Interface (hBCI) Sales Market Share by Type (2020-2025)
2.3.2 Global Hybrid Brain–Computer Interface (hBCI) Revenue and Market Share by Type (2020-2025)
2.3.3 Global Hybrid Brain–Computer Interface (hBCI) Sale Price by Type (2020-2025)
2.4 Hybrid Brain–Computer Interface (hBCI) Segment by Application
2.4.1 Healthcare
2.4.2 Entertainment and Education
2.4.3 Others
2.5 Hybrid Brain–Computer Interface (hBCI) Sales by Application
2.5.1 Global Hybrid Brain–Computer Interface (hBCI) Sale Market Share by Application (2020-2025)
2.5.2 Global Hybrid Brain–Computer Interface (hBCI) Revenue and Market Share by Application (2020-2025)
2.5.3 Global Hybrid Brain–Computer Interface (hBCI) Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Hybrid Brain–Computer Interface (hBCI) Breakdown Data by Company
3.1.1 Global Hybrid Brain–Computer Interface (hBCI) Annual Sales by Company (2020-2025)
3.1.2 Global Hybrid Brain–Computer Interface (hBCI) Sales Market Share by Company (2020-2025)
3.2 Global Hybrid Brain–Computer Interface (hBCI) Annual Revenue by Company (2020-2025)
3.2.1 Global Hybrid Brain–Computer Interface (hBCI) Revenue by Company (2020-2025)
3.2.2 Global Hybrid Brain–Computer Interface (hBCI) Revenue Market Share by Company (2020-2025)
3.3 Global Hybrid Brain–Computer Interface (hBCI) Sale Price by Company
3.4 Key Manufacturers Hybrid Brain–Computer Interface (hBCI) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hybrid Brain–Computer Interface (hBCI) Product Location Distribution
3.4.2 Players Hybrid Brain–Computer Interface (hBCI) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Hybrid Brain–Computer Interface (hBCI) by Geographic Region
4.1 World Historic Hybrid Brain–Computer Interface (hBCI) Market Size by Geographic Region (2020-2025)
4.1.1 Global Hybrid Brain–Computer Interface (hBCI) Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Hybrid Brain–Computer Interface (hBCI) Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Hybrid Brain–Computer Interface (hBCI) Market Size by Country/Region (2020-2025)
4.2.1 Global Hybrid Brain–Computer Interface (hBCI) Annual Sales by Country/Region (2020-2025)
4.2.2 Global Hybrid Brain–Computer Interface (hBCI) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Hybrid Brain–Computer Interface (hBCI) Sales Growth
4.4 APAC Hybrid Brain–Computer Interface (hBCI) Sales Growth
4.5 Europe Hybrid Brain–Computer Interface (hBCI) Sales Growth
4.6 Middle East & Africa Hybrid Brain–Computer Interface (hBCI) Sales Growth
5 Americas
5.1 Americas Hybrid Brain–Computer Interface (hBCI) Sales by Country
5.1.1 Americas Hybrid Brain–Computer Interface (hBCI) Sales by Country (2020-2025)
5.1.2 Americas Hybrid Brain–Computer Interface (hBCI) Revenue by Country (2020-2025)
5.2 Americas Hybrid Brain–Computer Interface (hBCI) Sales by Type (2020-2025)
5.3 Americas Hybrid Brain–Computer Interface (hBCI) Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hybrid Brain–Computer Interface (hBCI) Sales by Region
6.1.1 APAC Hybrid Brain–Computer Interface (hBCI) Sales by Region (2020-2025)
6.1.2 APAC Hybrid Brain–Computer Interface (hBCI) Revenue by Region (2020-2025)
6.2 APAC Hybrid Brain–Computer Interface (hBCI) Sales by Type (2020-2025)
6.3 APAC Hybrid Brain–Computer Interface (hBCI) Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Hybrid Brain–Computer Interface (hBCI) by Country
7.1.1 Europe Hybrid Brain–Computer Interface (hBCI) Sales by Country (2020-2025)
7.1.2 Europe Hybrid Brain–Computer Interface (hBCI) Revenue by Country (2020-2025)
7.2 Europe Hybrid Brain–Computer Interface (hBCI) Sales by Type (2020-2025)
7.3 Europe Hybrid Brain–Computer Interface (hBCI) Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Hybrid Brain–Computer Interface (hBCI) by Country
8.1.1 Middle East & Africa Hybrid Brain–Computer Interface (hBCI) Sales by Country (2020-2025)
8.1.2 Middle East & Africa Hybrid Brain–Computer Interface (hBCI) Revenue by Country (2020-2025)
8.2 Middle East & Africa Hybrid Brain–Computer Interface (hBCI) Sales by Type (2020-2025)
8.3 Middle East & Africa Hybrid Brain–Computer Interface (hBCI) Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hybrid Brain–Computer Interface (hBCI)
10.3 Manufacturing Process Analysis of Hybrid Brain–Computer Interface (hBCI)
10.4 Industry Chain Structure of Hybrid Brain–Computer Interface (hBCI)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hybrid Brain–Computer Interface (hBCI) Distributors
11.3 Hybrid Brain–Computer Interface (hBCI) Customer
12 World Forecast Review for Hybrid Brain–Computer Interface (hBCI) by Geographic Region
12.1 Global Hybrid Brain–Computer Interface (hBCI) Market Size Forecast by Region
12.1.1 Global Hybrid Brain–Computer Interface (hBCI) Forecast by Region (2026-2031)
12.1.2 Global Hybrid Brain–Computer Interface (hBCI) Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Hybrid Brain–Computer Interface (hBCI) Forecast by Type (2026-2031)
12.7 Global Hybrid Brain–Computer Interface (hBCI) Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Neuralink
13.1.1 Neuralink Company Information
13.1.2 Neuralink Hybrid Brain–Computer Interface (hBCI) Product Portfolios and Specifications
13.1.3 Neuralink Hybrid Brain–Computer Interface (hBCI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Neuralink Main Business Overview
13.1.5 Neuralink Latest Developments
13.2 NeuroSky
13.2.1 NeuroSky Company Information
13.2.2 NeuroSky Hybrid Brain–Computer Interface (hBCI) Product Portfolios and Specifications
13.2.3 NeuroSky Hybrid Brain–Computer Interface (hBCI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 NeuroSky Main Business Overview
13.2.5 NeuroSky Latest Developments
13.3 NeuroPace
13.3.1 NeuroPace Company Information
13.3.2 NeuroPace Hybrid Brain–Computer Interface (hBCI) Product Portfolios and Specifications
13.3.3 NeuroPace Hybrid Brain–Computer Interface (hBCI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 NeuroPace Main Business Overview
13.3.5 NeuroPace Latest Developments
13.4 EMOTIV
13.4.1 EMOTIV Company Information
13.4.2 EMOTIV Hybrid Brain–Computer Interface (hBCI) Product Portfolios and Specifications
13.4.3 EMOTIV Hybrid Brain–Computer Interface (hBCI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 EMOTIV Main Business Overview
13.4.5 EMOTIV Latest Developments
13.5 Blackrock Neurotech
13.5.1 Blackrock Neurotech Company Information
13.5.2 Blackrock Neurotech Hybrid Brain–Computer Interface (hBCI) Product Portfolios and Specifications
13.5.3 Blackrock Neurotech Hybrid Brain–Computer Interface (hBCI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Blackrock Neurotech Main Business Overview
13.5.5 Blackrock Neurotech Latest Developments
13.6 Compumedics
13.6.1 Compumedics Company Information
13.6.2 Compumedics Hybrid Brain–Computer Interface (hBCI) Product Portfolios and Specifications
13.6.3 Compumedics Hybrid Brain–Computer Interface (hBCI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Compumedics Main Business Overview
13.6.5 Compumedics Latest Developments
13.7 Advanced Brain Monitoring
13.7.1 Advanced Brain Monitoring Company Information
13.7.2 Advanced Brain Monitoring Hybrid Brain–Computer Interface (hBCI) Product Portfolios and Specifications
13.7.3 Advanced Brain Monitoring Hybrid Brain–Computer Interface (hBCI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Advanced Brain Monitoring Main Business Overview
13.7.5 Advanced Brain Monitoring Latest Developments
13.8 G.TEC
13.8.1 G.TEC Company Information
13.8.2 G.TEC Hybrid Brain–Computer Interface (hBCI) Product Portfolios and Specifications
13.8.3 G.TEC Hybrid Brain–Computer Interface (hBCI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 G.TEC Main Business Overview
13.8.5 G.TEC Latest Developments
13.9 Neuroelectrics
13.9.1 Neuroelectrics Company Information
13.9.2 Neuroelectrics Hybrid Brain–Computer Interface (hBCI) Product Portfolios and Specifications
13.9.3 Neuroelectrics Hybrid Brain–Computer Interface (hBCI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Neuroelectrics Main Business Overview
13.9.5 Neuroelectrics Latest Developments
13.10 Brain Products
13.10.1 Brain Products Company Information
13.10.2 Brain Products Hybrid Brain–Computer Interface (hBCI) Product Portfolios and Specifications
13.10.3 Brain Products Hybrid Brain–Computer Interface (hBCI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Brain Products Main Business Overview
13.10.5 Brain Products Latest Developments
13.11 ANT Neuro
13.11.1 ANT Neuro Company Information
13.11.2 ANT Neuro Hybrid Brain–Computer Interface (hBCI) Product Portfolios and Specifications
13.11.3 ANT Neuro Hybrid Brain–Computer Interface (hBCI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 ANT Neuro Main Business Overview
13.11.5 ANT Neuro Latest Developments
13.12 BrainCo
13.12.1 BrainCo Company Information
13.12.2 BrainCo Hybrid Brain–Computer Interface (hBCI) Product Portfolios and Specifications
13.12.3 BrainCo Hybrid Brain–Computer Interface (hBCI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 BrainCo Main Business Overview
13.12.5 BrainCo Latest Developments
13.13 Neuracle
13.13.1 Neuracle Company Information
13.13.2 Neuracle Hybrid Brain–Computer Interface (hBCI) Product Portfolios and Specifications
13.13.3 Neuracle Hybrid Brain–Computer Interface (hBCI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Neuracle Main Business Overview
13.13.5 Neuracle Latest Developments
13.14 Flexolink
13.14.1 Flexolink Company Information
13.14.2 Flexolink Hybrid Brain–Computer Interface (hBCI) Product Portfolios and Specifications
13.14.3 Flexolink Hybrid Brain–Computer Interface (hBCI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Flexolink Main Business Overview
13.14.5 Flexolink Latest Developments
13.15 NeuralFlex
13.15.1 NeuralFlex Company Information
13.15.2 NeuralFlex Hybrid Brain–Computer Interface (hBCI) Product Portfolios and Specifications
13.15.3 NeuralFlex Hybrid Brain–Computer Interface (hBCI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 NeuralFlex Main Business Overview
13.15.5 NeuralFlex Latest Developments
14 Research Findings and Conclusion

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

Ěý

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

Ěý

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/lpi/global-hybrid-brain%E2%80%93computer-interface-hbci-market-growth-2025-2031

Links
[1] /countries/global[2] /semiconductors[3] /manufacturing-computing-electronics[4] /computing-electronics